Jun 15, 2026 09:32AM
Jun 12, 2026 06:53AM
Jun 11, 2026 07:03AM
Jun 11, 2026 07:02AM
Jun 10, 2026 05:08PM
Jun 3, 2026 07:00AM
Jun 3, 2026 06:52AM H.C. Wainwright Reiterates Buy Rating on Syndax Pharmaceuticals (SNDX)
Jun 2, 2026 04:01PM
May 21, 2026 05:01PM
May 4, 2026 07:24AM
May 1, 2026 04:10PM
May 1, 2026 03:12PM
May 1, 2026 04:38AM
Apr 30, 2026 04:28PM Syndax Pharmaceuticals (SNDX) Tops Q1 EPS by 14c
Apr 23, 2026 02:16PM
Mar 30, 2026 08:57AM
Mar 27, 2026 04:14PM
Mar 16, 2026 02:04PM
Feb 27, 2026 12:03PM
Feb 26, 2026 04:40PM
Feb 4, 2026 06:51AM B.Riley Reiterates Buy Rating on Syndax Pharmaceuticals (SNDX)
Jan 12, 2026 07:08AM
Dec 9, 2025 06:55AM
Dec 9, 2025 04:34AM
Dec 8, 2025 06:50AM
Nov 4, 2025 09:31AM
Nov 4, 2025 04:21AM
Nov 3, 2025 04:05PM Syndax Pharmaceuticals (SNDX) Tops Q3 EPS by 3c
Nov 3, 2025 09:09AM
Oct 27, 2025 07:48AM
Oct 24, 2025 01:08PM
Oct 24, 2025 12:57PM
Oct 16, 2025 06:39AM
Oct 16, 2025 06:16AM
Sep 19, 2025 07:00AM NCCN adds Syndax's Revuforj to leukemia treatment guidelines
Sep 10, 2025 01:59AM
Sep 4, 2025 05:41AM
Aug 6, 2025 08:01AM
Aug 5, 2025 11:15AM
Aug 5, 2025 06:26AM
Aug 5, 2025 05:12AM
Aug 4, 2025 04:55PM Syndax Pharmaceuticals (SNDX) Tops Q2 EPS by 18c
Jul 21, 2025 03:36PM
Jul 21, 2025 10:58AM
Jul 15, 2025 06:21AM
Jul 10, 2025 02:25AM
Jun 24, 2025 04:02PM
Jun 12, 2025 12:03PM
Jun 12, 2025 07:00AM Syndax Pharmaceuticals (SNDX) Presents New Revuforj Data in Relapsed/Refractory mNPM1 and NUP98r Acute Leukemia from AUGMENT-101 Trial
May 25, 2025 03:00PM

404,876 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All